A PE-PGRS33 protein of Mycobacterium tuberculosis: An ideal target for future tuberculosis vaccine design

Paola Gastelum-Aviña, Carlos Velazquez, Clara Espitia, Fernando Lares-Villa, Adriana Garibay-Escobar

Research output: Contribution to journalScientific reviewpeer-review

9 Scopus citations

Abstract

© Informa UK, Ltd. It is known that cellular immune response is relevant to fight against tuberculosis (TB); hence, identification of mycobacterial antigens that induce a protective immune cellular response is of great interest, especially for the development of effective TB vaccines. Genomic data have an impact on the identification of potential antigens as new vaccine targets. In this review, we summarize the current knowledge about the advances in new TB vaccine designs as well as the features reported for the pro-glu-polymorphic GC-rich sequence (PE-PGRS33) protein, considering this molecule as a prototype of the PE-PGRS family to better understand the biological function of this protein family that could be considered an ideal target for future vaccine design.
Original languageAmerican English
Pages (from-to)699-711
Number of pages13
JournalExpert Review of Vaccines
DOIs
StatePublished - 1 Jan 2015

Fingerprint

Dive into the research topics of 'A PE-PGRS33 protein of Mycobacterium tuberculosis: An ideal target for future tuberculosis vaccine design'. Together they form a unique fingerprint.

Cite this